Ferran Torres, MD, PhD
Short Professional Extract
Ferran Torres (1964-), MD, PhD, Medical doctor (1988), Clinical Pharmacology medical speciality (1992), PhD (Methodological and Statistical Issues of Sequential Clinical Trials, 1998), with almost 30 years experience in the design and analysis of clinical trials and other studies in the hospital and university settings (1992-).
More than 280 published papers in indexed scientific journals with a cumulated IF of >1.500, h-index>64. [Pubs from 2000-].
Collaboration with Scientific Journals:
Associate editor of the Trials Journal (2015-2018); Statistical reviewer for ;Statistical Advisory Board of PlosOne; Peer reviewer for a number of scientific journals (Journal of Biopharmaceutical Statistics, Clinical Rheumatology, Trials, European Journal of Clinical Pharmacology, Medicina Clínica, Archivos de Bronconeumologia, etc.)
Regulatory Scientific & Statistics activities:
Medical and statistical consultant to the Spanish Medicines Agency (AEMPS, 1999-); member of the Scientific Advice Working Party (SAWP, 2008-2021) and the Biostatistics Working Party (BSWP, full member 2009-2018, observer 2020-) groups at the European Medicines Agency (EMA).
Active collaborator of the ECRIN network: Member of the Independent Certification Board (ICB), (2011-), Spanish representative to the Data Management group (2003-2019). Permanent external reviewer of the ECRIN standard procedures (2013-2019).
Chair (2014-2018) and Vice-Chair (2018-2020) of the Biostatistics and Data Management Program of the Spanish Clinical Research Network (SCReN), Platform funded by the ISCiii to promote the independent clinical investigation (2013-2021) Plataforma de Unidades de Investigación Clínica y Ensayos Clínicos (general info in spanish).
Methodologies for rare diseases:
Principal investigator of WP5 (Validation of new methods within clinical as well as regulatory settings) for the FP7 project on rare diseases ASTERIX (Advances in Small Trials dEsign for Regulatory Innovation and eXcellence ASTERIX) (2014-2018). This project is specifically designed to optimize methodology for clinical trials in small populations to achieve more reliable and cost efficient clinical development of treatments for rare diseases. (FP7-HEALTH-2013-INNOVATION-1, Grant-Agreement No. 603160).
Orphan diseases and collaboration with EURORDIS network.
Coordinator and professor to several training, doctorate courses and masters of methodological-statistical issues on clinical investigation.
- ResearchGate => https://www.researchgate.net/profile/Ferran_Torres
- ResearcherId: D-1296-2011 => http://www.researcherid.com/rid/D-1296-2011
- ORCID: 0000-0002-7355-7913 => http://orcid.org/0000-0002-7355-7913
- SCOPUS: 7102336718 => http://www.scopus.com/authid/detail.url?authorId=7102336718
- My NCBI: => https://www.ncbi.nlm.nih.gov/myncbi/1dWccHdH748/bibliography/public/
- Publons: => https://publons.com/researcher/2797921/ferran-torres/